Viking Therapeutics, Inc.
VKTXW
VKTXW was delisted on the 8th of April, 2021.
6 hedge funds and large institutions have $648K invested in Viking Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
50% more funds holding
Funds holding: 4 → 6 (+2)
11% less capital invested
Capital invested by funds: $731K → $648K (-$83K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$304K |
| 2 |
William Blair & Company
Chicago,
Illinois
|
+$104K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$409 |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$542K |
| 2 |
VF
Virtu Financial
New York
|
-$109K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PWAM
1
Park West Asset Management
San Francisco,
California
| $289K | – | – | – |
|
|
2
DZ Bank
Frankfurt Am Main,
Germany
| $230K | +$304K | +74,285 | New |
|
|
3
William Blair & Company
Chicago,
Illinois
| $77K | +$104K | +25,520 | New |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $43K | -$542K | -132,588 | -90% |
|
|
5
UBS Group
Zurich,
Switzerland
| $9K | -$1.28K | -312 | -9% |
|
|
VF
6
Virtu Financial
New York
| – | -$109K | -43,100 | Closed |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | +$409 | +100 | New |
|
VKTXW Hedge Fund Activity: Q1 2018 in Review
6 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q1 2018, worth a combined $648K — down 11% from $731K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new VKTXW positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was DZ Bank, opening a new position worth an estimated $304K. The largest seller was Susquehanna International Group, cutting an estimated $542K.
- 6 institutional investors held Viking Therapeutics, Inc. (VKTXW) as of Q1 2018, up from 4 in Q4 2017.
- Funds reported $648K of Viking Therapeutics, Inc. stock for Q1 2018, down 11% quarter-over-quarter.
- 3 funds opened new Viking Therapeutics, Inc. positions in Q1 2018 and 1 closed out, a net change of +2 holders.
- The largest Viking Therapeutics, Inc. buyer in Q1 2018 was DZ Bank, an estimated $304K added.
- The largest Viking Therapeutics, Inc. seller in Q1 2018 was Susquehanna International Group, an estimated $542K sold.
Based on aggregated 13F filings for Q1 2018.